Iovance Biotherapeutics Statistics
Total Valuation
IOVA has a market cap or net worth of $3.46 billion. The enterprise value is $3.13 billion.
Important Dates
The last earnings date was Thursday, November 5, 2026, before market open.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IOVA has 462.66 million shares outstanding. The number of shares has increased by 30.80% in one year.
| Current Share Class | 462.66M |
| Shares Outstanding | 462.66M |
| Shares Change (YoY) | +30.80% |
| Shares Change (QoQ) | +1.27% |
| Owned by Insiders (%) | 6.42% |
| Owned by Institutions (%) | 54.99% |
| Float | 403.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.10 |
| Forward PS | 6.17 |
| PB Ratio | 4.29 |
| P/TBV Ratio | 6.23 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.20, with a Debt / Equity ratio of 0.06.
| Current Ratio | 5.20 |
| Quick Ratio | 4.57 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -29.11% and return on invested capital (ROIC) is -17.86%.
| Return on Equity (ROE) | -29.11% |
| Return on Assets (ROA) | -15.19% |
| Return on Invested Capital (ROIC) | -17.86% |
| Return on Capital Employed (ROCE) | -26.02% |
| Weighted Average Cost of Capital (WACC) | 8.74% |
| Revenue Per Employee | $388,701 |
| Profits Per Employee | -$226,190 |
| Employee Count | 975 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 3.31 |
Taxes
| Income Tax | -1.24M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +209.09% in the last 52 weeks. The beta is 0.84, so IOVA's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | +209.09% |
| 50-Day Moving Average | 11.27 |
| 200-Day Moving Average | 6.19 |
| Relative Strength Index (RSI) | 31.51 |
| Average Volume (20 Days) | 15,147,838 |
Short Selling Information
The latest short interest is 65.19 million, so 14.09% of the outstanding shares have been sold short.
| Short Interest | 65.19M |
| Short Previous Month | 58.93M |
| Short % of Shares Out | 14.09% |
| Short % of Float | 16.14% |
| Short Ratio (days to cover) | 4.24 |
Income Statement
In the last 12 months, IOVA had revenue of $378.98 million and -$220.54 million in losses. Loss per share was -$0.51.
| Revenue | 378.98M |
| Gross Profit | 201.75M |
| Operating Income | -230.38M |
| Pretax Income | -221.78M |
| Net Income | -220.54M |
| EBITDA | -192.91M |
| EBIT | -230.38M |
| Loss Per Share | -$0.51 |
Full Income Statement Balance Sheet
The company has $376.32 million in cash and $45.21 million in debt, with a net cash position of $331.11 million or $0.72 per share.
| Cash & Cash Equivalents | 376.32M |
| Total Debt | 45.21M |
| Net Cash | 331.11M |
| Net Cash Per Share | $0.72 |
| Equity (Book Value) | 812.66M |
| Book Value Per Share | 1.76 |
| Working Capital | 443.86M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$189.95 million and capital expenditures -$26.11 million, giving a free cash flow of -$216.06 million.
| Operating Cash Flow | -189.95M |
| Capital Expenditures | -26.11M |
| Depreciation & Amortization | 37.47M |
| Net Borrowing | n/a |
| Free Cash Flow | -216.06M |
| FCF Per Share | -$0.47 |
Full Cash Flow Statement Margins
Gross margin is 53.23%, with operating and profit margins of -60.79% and -58.19%.
| Gross Margin | 53.23% |
| Operating Margin | -60.79% |
| Pretax Margin | -58.52% |
| Profit Margin | -58.19% |
| EBITDA Margin | -50.90% |
| EBIT Margin | -60.79% |
| FCF Margin | n/a |
Dividends & Yields
IOVA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -30.80% |
| Shareholder Yield | -30.80% |
| Earnings Yield | -6.80% |
| FCF Yield | -6.26% |
Analyst Forecast
The average price target for IOVA is $14.50, which is 93.85% higher than the current price. The consensus rating is "Buy".
| Price Target | $14.50 |
| Price Target Difference | 93.85% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 52.11% |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on September 26, 2013. It was a reverse split with a ratio of 1:100.
| Last Split Date | Sep 26, 2013 |
| Split Type | Reverse |
| Split Ratio | 1:100 |
Scores
IOVA has an Altman Z-Score of 1.98 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.98 |
| Piotroski F-Score | 4 |